VLB

(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE

VLB as a free ligand exists in 4 entries. Examples include: 4EB6 1Z2B 5BMV

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

Name(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE
Identifiersn/a
FormulaC46 H58 N4 O9
Molecular Weight810.97
TypeNON-POLYMER
Isomeric SMILESCC[C@]1(O)C[C@@H]2C[N@](C1)CCc1c([nH]c3ccccc13)[C@@](C2)(C(=O)OC)c1cc2c(cc1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)(C23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC
InChIInChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1
InChIKeyJXLYSJRDGCGARV-CFWMRBGOSA-N

Chemical Details

Formal Charge0
Atom Count117
Chiral Atom Count9
Chiral AtomsC12, C19, C2, C3, C4, C5, C52, C54, C68
Bond Count125
Aromatic Bond Count16
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00570 Different stereochemistry
NameVinblastine
Groupsapproved
DescriptionAntitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.)
Synonyms
  • (2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine
  • Vinblastin
  • Vinblastina
  • Vinblastine
  • Vinblastinum
SaltsVinblastine Sulfate
Brand Names
  • Velbe 1mg/ml
  • Vinblastine Sulfate
  • Vinblastine Sulfate Inj 1mg/ml
  • Vinblastine Sulfate Injection
  • Vinbla
Affected OrganismHumans and other mammals
IndicationFor treatment of breast cancer, testicular cancer, lymphomas, neuroblastoma, Hodgkin's and non-Hodgkin's lymphomas, mycosis fungoides, histiocytosis, and Kaposi's sarcoma.
PharmacologyVinblastine is a vinca alkaloid antineoplastic agent. The vinca alkaloids are structurally similar compounds comprised of 2 multiringed units: vindoline and catharanthine. The vinca alkaloids have become clinically useful since the discovery of their antitumour properties in 1959. Initially, extracts of the periwinkle plant (<i>Catharanthus roseus</i>) were investigated because of putative hypoglycemic properties, but were noted to cause marrow suppression in rats and antileukemic effects <i>in vitro</i>. Vinblastine has some immunosuppressant effect. The vinca alkaloids are considered to be cell cycle phase-specific.
Mechanism of actionThe antitumor activity of vinblastine is thought to be due primarily to inhibition of mitosis at metaphase through its interaction with tubulin. Vinblastine binds to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest or cell death.
Route of administrationIntravenous
Categories
  • Alkaloids
  • Antimitotic Agents
  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Antineoplastic and Immunomodulating Agents
ATC-CodeL01CA01
AHFS-Code10:00.00
CAS number865-21-4
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682